The expression of NEK2 and aerobic glycolysis genes was examined in plasma cells derived from 22 healthy subjects, 44 monoclonal gammopathy of undetermined significance (MGUS) patients, 305 low- and 46 high-risk myeloma patients using gene expression profiling (GEP). This evidence concerns the gene NEK2 and plasma cell myeloma.